Juvent joins the 2025 Inc. 5000, ranking #757 with 552% growth over 3 years, for its Micro-Impact Platform, which improves mobility, pain, and wellness.
Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd.
VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- Late last week as global equities rose,...
Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd.
VANCOUVER, BC, Aug. 12, 2025 /CNW/ -- Late last week as global equities rose,...
Equity Insider News CommentaryIssued on behalf of Lake Victoria Gold Ltd.
VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- Late last week as global equities rose,...
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH) (“Blockmate” or the “Company”) is pleased to announce that its investee, Hivello Holdings, has successfully integrated DePIN Theta Network with the Hivello platform to increase passive income earning opportunities for Hivello users.
iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scan
GUIYANG, China, Aug. 11, 2025 /PRNewswire/ -- A news report by Huanqiu.com
As the digital economy develops rapidly, computing power has become the core engine...
SINGAPORE, Aug. 12, 2025 /PRNewswire/ -- Granite Asia today announced the appointment of three new Managing Partners, further strengthening the firm's leadership across equity...
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (“Westport") (TSX:WPRT / Nasdaq:WPRT), a supplier of alternative fuel systems and components for the global transportation industry, reported financial results for the second quarter ended June 30, 2025, and provided an update on operations. All figures are in U.S. dollars unless otherwise stated.
Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 Cervical Cancer Patients. The report outlines how cutting-edge immunotherapy is reshaping care for women with advanced cervical cancer, offering new pathways to longer survival and improved quality of life, particularly in cases resistant to standard treatments.
Stephen Hahn to Transition to CEO Emeritus and Special Advisor and remain on Harbinger's board
CAMBRIDGE, Mass., Aug. 11, 2025 /PRNewswire/ -- Flagship Pioneering, the...
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.